Puspendu Ghosh

4PUBLICATIONS
20CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 20, 2026
S1P-S1PR1 signaling impairs CD8+ T cell metabolism and effector function in tumors.

Debashree Basak, Puspendu Ghosh, Anupam Gautam

|Mar 21, 2025
CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor.

Ishita Sarkar, Debashree Basak, Puspendu Ghosh

|Mar 07, 2024
CD38-RyR2 axis-mediated signaling impedes CD8+ T cell response to anti-PD1 therapy in cancer.

Anwesha Kar, Puspendu Ghosh, Anupam Gautam

|Jun 01, 2022
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells.

Snehanshu Chowdhury, Anwesha Kar, Debaleena Bhowmik

Pageof 1